Abstract. Lung ischemia-reperfusion can cause acute lung injury, which is closely associated with apoptosis. Heat shock protein 70 (HSP70) is an anti-apoptotic protein that promotes cell survival under a variety of different stress conditions. However, the role and mechanism of HSP70 in lung ischemia-reperfusion injury is yet to be fully elucidated. In the present study, an in vitro hypoxia/reoxygenation model of A549 cells was established to simulate lung ischemia-reperfusion and HSP70 was silenced by transfecting A549 cells with an shRNA sequence targeting HSP70. Western blotting, reverse transcription-quantitative polymerase chain reaction, Cell Counting kit-8 and flow cytometry were used to detect protein levels, RNA expression, cell activity and apoptosis. The results revealed that silencing HSP70 reduced cell viability, aggravated apoptosis, increased lactate dehydrogenase levels and induced a G2/M blockade in a hypoxia-reoxygenation A549 cell model. Furthermore, silencing HSP70 decreased the phosphorylation levels of protein kinase B (AKT) and extracellular signal-regulated kinase (ERK); however, the total AKT and ERK levels did not change significantly. Pretreating A549 cells with the AKT pathway inhibitor, LY294002 and the ERK pathway inhibitor, U0216 led to a decrease in HSP70 expression. These results indicate that silencing HSP70 may aggravate apoptosis in hypoxia-reoxygenation cell models, potentially via the mitogen-activated protein kinase/ERK and phosphoinositide 3-kinase/AKT signaling pathways.
Introduction
Lung ischemia-reperfusion injury (LIRI) is characterized by non-specific alveolar damage, lung edema, pulmonary hypertension and hypoxemia (1) , and has been implicated in several clinical conditions including cardiopulmonary resuscitation, lung transplantation and pulmonary embolism (2) (3) (4) . LIRI has a relatively complicated pathological mechanism, which serves an important role in apoptosis. Previous studies have revealed that cell apoptosis is associated with an increased risk of LIRI, indicating that anti-apoptosis may be a potential target to treat lung ischemic disease (5, 6) .
Heat shock protein 70 (HSP70) is highly conserved and is activated by stress stimulation (7) . The main function of HSP70 is to participate in the regulation of intracellular protein folding and to protect cells from stress damage (8, 9) . HSP70 has been demonstrated to affect anti-apoptotic functions (10) . A previous study have revealed that the overexpression of HSP70 effectively protects alveolar epithelial cells against apoptosis and antagonizes the effects of LIRI (11) . Furthermore, the overexpression of HSP70 also prevents proteins from misfolding and aggregating (12, 13) . The overexpression of HSP70 also attenuates ischemia-reperfusion injury (IRI) induced by lung transplantation (14) . In addition, several studies have reported that the overexpression of HSP70 reduces heart (15) and brain (16) IRI. However, to the best of our knowledge, the mechanism that underlies the protective effect of HSP70 on LIRI has not yet been elucidated.
The B-cell lymphoma (Bcl)-2 family of proteins is comprised of pro-apoptotic proteins, including BH3 interacting domain death agonist and Bcl-2-associated X (Bax), and anti-apoptotic proteins including Bcl-2 and Bcl-extra large. Jayanthi et al (17) demonstrated that Bcl-2 and Bax regulates apoptosis and that apoptosis is dependent on the ratio of Bcl-2/Bax; the lower the Bcl-2/Bax ratio, the more severe the level of apoptosis.
The caspase family are enzymatic proteins that serve key roles in the signal transduction of apoptosis (18) . One of the family members, caspase-3, is the core effector and main executor of apoptosis (19) (20, 21) . The two pathways are activated during lung ischemia (22, 23) , indicating that they may be involved in the pathological process of pulmonary ischemia. The present study assessed the protective effect of HSP70 on LIRI as well as its underlying mechanism. Levels of Bcl-2, Bax, caspase-3 and lactate dehydrogenase (LDH), and cell cycle and apoptotic rate were analyzed to assess the protective effects of HSP70. In addition, the expression of phosphorylated (p)-ERK and p-AKT were determined. Finally, the involvement of the MAPK/ERK and PI3K/AKT signaling pathways were evaluated using their respective inhibitors.
Materials and methods
Reagents and antibodies. Dulbecco's modified Eagle's medium (DMEM) and fetal bovine serum (FBS) were purchased from Hyclone (GE Healthcare Life Sciences, Logan, UT, USA). The anti-HSP70 antibody was purchased from Abcam (Cambridge, UK). The anti-Caspase-3, anti-Bcl-2, anti-Bax, anti-ERK, anti-p-ERK, anti-AKT, anti-p-AKT, anti-GAPDH and anti-β-Actin antibodies, as well as LY294002 (the PI3K/AKT inhibitor) and U0126 (the MAPK/ERK inhibitor) were all purchased from Cell Signaling Technology, Inc. (Danvers, MA, USA).
Cell culture. A549 cells (Type Culture Collection of the Chinese Academy of Sciences, Shanghai, China) were cultured and passaged in DMEM containing 10% FBS at 37˚C in a humidified atmosphere with 5% CO 2 . Cells were divided into three groups: The recombinant lentiviral infection group (lentivirus mediated knockdown of the HSP70 gene), the lentivirus control group (empty lentiviral vector) and the non-infection group.
Infection. A549 cells were transfected with a lentiviral overexpression vector (1x10 7 TU/ml; Shanghai GeneChem Co., Ltd., Shanghai, China) that expressed HSP70 and green fluorescent protein (GFP). The lentiviral vector containing an shRNA sequence (5'-GGA CGA GTT TGA GCA CAA G-3'), which targeted HSP70 or the lentiviral vector backbone according to the manufacturer's protocol. Briefly, 4x10 4 cells/well were seeded into 24-well plate and incubated at 37˚C in 5% CO 2 overnight. According to the pretesting, 20 µl lentivirus liquid, 80 µl Enhanced Infection Solution, 50 µg/ml polybrene (both Shanghai GeneChem Co., Ltd.) and 800 µl DMEM were added directly onto the cell monolayer. After incubating at 37˚C for 12 h, the normal DMEM was added. After 48 h of lentivirus transfection, GFP-transfected cells and total cells were counted by two researchers independently under a fluorescence microscope (each researcher randomly selected 5-7 fields of vision at a magnification of x400 and counted more than 700 cells). The average infection rate was calculated as follows: Infection rate=green fluorescent cells/total cells x 100%. Stable cells were screened by puromycin (Invitrogen; Thermo Fisher Scientific, Inc., Waltham, MA, USA) for culture and passaged.
Hypoxia/reoxygenation cell model. A549 cells were cultured in DMEM without glucose or serum and placed in a hypoxic environment at 37˚C for 2, 4, 6, 8 and 10 h. Hypoxic conditions were established using an Anaeropack (Mitsubishi Gas Chemical Company, Inc., Tokyo, Japan), which contained sodium ascorbate as the principal ingredient to absorb oxygen and generate the same volume of carbon dioxide via oxidative degradation in a sealed container (24) . Subsequently, glucose-free DMEM (Beijing Solarbio Science & Technology Co., Ltd., Beijing, China) was replaced with normal DMEM and the cells were cultured in a reoxygenated environment with 21% O 2 and 5% CO 2 for 24 h at 37˚C. U0126 or LY294002 were dissolved in dimethyl sulfoxide (DMSO). The stock solutions were prepared with minimal exposure to air and light, and stored at -20˚C for 1 h prior to hypoxia/reoxygenation treatment. Then 10 µM U0126 or 50 µM LY294002 from the stock solutions were added to the uninfected A549 cells (the U0126 group) before hypoxia/reoxygenation. DMSO was added to the non-infection, lentivirus control and lentiviral infection groups.
Cell viability assay. A549 cells were seeded at a density of 8x10 3 in 96-well plates and incubated at 37˚C for 24 h. Subsequently, cells were exposed to hypoxic conditions for 2, 4, 6, 8 and 10 h and reoxygenized for a further 24 h. Finally, 10 µl of Cell Counting kit-8 (CCK-8; Wuhan Boster Biological Technology, Ltd., Wuhan, China) solution was added to each well according to the manufactures protocol and incubated at 37˚C for 1 h. The absorbance of each well was then measured at 450 nm using a microplate reader.
Apoptosis analysis. Following 6 h of hypoxia and 24 h of reoxygenation, the three groups of cells were collected with 0.25% trypsin. An Annexin V-allophycocyanin/propidium iodide (PI) staining kit (eBioscience; Thermo Fisher Scientific, Inc.) was utilized for the detection of apoptosis according to the manufacturer's protocol. Following washing with PBS and binding buffer, the cells were resuspended in Annexin V binding buffer (1x10 6 cells/ml). Subsequently, 5 µl of fluorochrome-conjugated Annexin V was added to 100 µl of cell suspension and incubated for 10-15 min at room temperature. Cells were then further washed with binding buffer and resuspended in 200 µl of binding buffer.
A total of 5 µl of the PI staining solution was added to the cell suspension, which was then analyzed using a FACStar Plus flow cytometer (BD Biosciences, Franklin Lakes, NJ, USA). Data analysis was performed with BD Accuri C6 software (BD Biosciences).
Cell cycle analysis. A PI Flow Cytometry kit (Abcam) was used to determine cell cycle status with a flow cytometer. The three groups of cells were cultured under hypoxic conditions for 6 h and then reoxygenated for 24 h prior to being harvested into a single cell suspension. According to the manufacturer's protocol, the cells were fixed in 66% ethanol at 4˚C for 2 h, rehydration in PBS and stained with PI + RNase from the PI Flow Cytometry kit at 4˚C for 30 min. Finally, the fluorescence intensity of PI was measured at 488 nM on FL2 using a flow cytometer. Data analysis was performed with FlowJo VX10 software (FlowJo LLC, Ashland, OR, USA).
Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) detection. Total RNA was extracted using TRIzol (Invitrogen; Thermo Fisher Scientific, Inc.) and reverse transcribed into cDNA with PrimeScript RT reagent kit (Takara Bio, Inc., Otsu, Japan). Briefly, 1 µg total RNA of each sample was used for each reaction in a 20 µl reaction mixture. After removing genomic DNA using gDNA Eraser (Takara Bio, Inc.), cDNA was synthesized at 37˚C for 15 min. qPCR was performed using cDNA as a template with the FastStart Essential DNA Green Master kit (Roche Diagnostics, Basel, Switzerland) and β-actin as a reference. The reaction conditions included an initial pre-denaturation at 95˚C for 10 min, followed by 45 cycles of 95˚C for 15 sec, 60˚C for 20 sec and 72˚C for 15 sec. After the termination of the PCR, the production was analyzed by the LightCycler96 System (Roche Diagnostics, GmbH, Mannheim, Germany) automatically. The primers used were as follows: β-actin forward, 5'-GAT GAG ATT GGC ATG GCT TT-3' and reverse, 5'-CAC CTT CAC CGT TCC AGT TT-3'; HSP70 forward, 5'-CAA GAA GAA GGT GCT GGA CA-3' and reverse, 5'-GTA CAG TCC GCT GAT GAT GG-3'. The relative level of HSP70 mRNA was calculated using the 2 -ΔΔCq method (25) . 
Results

Lentiviral transfection inhibits the expression of HSP70.
At 48 h post-transfection, A549 cells appeared to be polygon-shaped, plump and interconnected under the fluorescence microscope (Fig. 1) . The infection rate of A549 cells, was ~80%. Compared with the lentivirus control group and the non-infection group, a significant decrease was observed in the mRNA ( Fig. 2A) and protein ( Fig. 2B and C) levels of HSP70 in the lentivirus infection group (P<0.05).
HSP70 silencing decreases A549 cell viability. In order to select the effective duration of hypoxia, the cell viability under hypoxic conditions was measured. The results of the CCK-8 assay revealed that, at 6 h, A549 cells had the highest marked viability compared with other time points (Fig. 3) . In addition, the viability of the lentivirus infection group was significantly lower than that of the lentivirus control and non-infection groups at all time points (P<0.05).
HSP70 silencing increases the number of apoptotic A549 cells following hypoxia and reoxygenation.
Following 6 h of hypoxia and 24 h of reoxygenation, the rate of apoptosis in the lentiviral infection group was significantly higher when compared with the other two groups (P<0.05; Fig. 4 ).
Hsp70 silencing increases caspase-3 expression and decreases the ratio of Bcl-2/Bax.
The results of western blotting revealed that the expression of caspase-3 in the lentiviral infection group was increased by ~80% when compared with the non-infection and lentivirus control groups (P<0.05; Fig. 5A and B) . Furthermore, the ratio of Bcl-2/Bax was decreased by 70.1% when compared with the lentivirus control group (P<0.05; Fig. 5A and C).
HSP70 silencing causes G2/M arrest.
The ratio of G2 and M phase cells in the lentiviral infection group was significantly higher than that of the non-infection and lentivirus control groups (P<0.05; Fig. 6 ).
HSP70 silencing promotes cellular LDH release. LDH levels in the lentiviral infection group were significantly higher when compared with the non-infection and lentivirus control groups (P<0.05; Fig. 7 ). These results indicate that HSP70 silencing promotes the release of LDH.
Influence of HSP70 on the MAPK/ERK signaling pathway.
Cells were exposed to hypoxia for 6 h and reoxygenation for 24 h with or without 10 µM U0126 pretreatment. The results revealed that treatment with 10 µM U0126 effectively inhibited ERK phosphorylation and decreased HSP70 expression compared with the non-infection group ( Fig. 8A and B) . In addition, HSP70 silencing decreased the level of p-ERK compared with the non-infection group (P<0.05; Fig. 8A and C) .
Influence of HSP70 on the PI3K/AKT signaling pathway.
Cells were exposed to hypoxia for 6 h and reoxygenation for 24 h with or without 50 µM LY294002 pretreatment. The results revealed that treatment with 50 µM LY294002 effectively inhibited AKT phosphorylation and decreased HSP70 expression compared with the non-infection group (P<0.05; Fig. 9A and B) . In addition, HSP70 silencing decreased the level of p-AKT compared with the non-infection group (P<0.05; Fig. 9A and C). Treatment with 10 µM U0126 and 50 µM LY294002 also reduced the mRNA level of HSP70 compared with the non-infection group (Fig. 10) .
Discussion
LIRI causes severe lung injury and involves a series of pathological processes including oxidative stress, inflammation and apoptosis (26, 27) . Apoptosis is an important method of cell death following LIRI (28). HSP70, a member of the most conserved family of HSPs, usually serves as a regulator and signaling molecule in certain cellular processes, such as cell damage resistance and repair, and protects cells from various stress-induced injuries, including apoptosis, oxidative stress and ischemic-reperfusion injury (29) . The high expression of HSP72 in alveolar epithelial cells induced by dimethylarsinic acid has been demonstrated to inhibit cell apoptosis (30) . Lipopolysaccharide-induced acute lung injury can also be protected against via an increased HSP70 expression (31) . In addition, the overexpression of HSP70 exhibits a protective effect on LIRI (11) . As aforementioned, HSP70 is an anti-apoptotic protein that provides protection against hypoxic/reoxygenation injuries (32). In the current study, HSP70 silenced A549 cells exhibited a marked reduction in Bcl-2 and a marked increase of Bax and caspase-3. Furthermore, apoptotic rates were increased, indicating an increase in cellular apoptosis. LDH is an important indicator of cell injury and as such was assessed in the present study. The results of LDH analysis revealed that HSP70 silencing increased the release of LDH in cells, indicating an increase in cell injury. The results of the current study therefore revealed that HSP70 silencing aggravated cell injury and apoptosis in a model of hypoxia-reoxygenation. Thus, it was inferred that the cytoprotective effect of HSP70 on LIRI may be associated with anti-apoptosis and the mitigation of cell injury. Interestingly, the authors of the current study found that the proliferation of A549 cells increased following 6 h of hypoxia. This may be because a short period of hypoxia stimulates cell proliferation, but long-term hypoxia reduces cell activity (33,34).
All phases, including G2/M, have detection points for cell cycle regulation. DNA damage caused by various factors can lead to G2/M phase arrest, which is closely associated with apoptosis (35) . The results of the present study revealed that HSP70 silencing resulted in G2/M arrest in A549 cells following hypoxia/reoxygenation, reducing cell proliferation. It is possible that apoptosis induced by HSP70 silencing may therefore be associated with cell cycle arrest.
ERK is a serine/threonine protein kinase and belongs to the MAPK family (36) . It is an important transduction protein that transmits mitogen signals within the body (37) . AKT is a direct target gene of PI3K. Activating PI3K can phosphorylate Akt, which causes downstream phosphorylation cascades and interactions between target proteins, thus regulating cell survival and apoptosis (38) . It has been demonstrated that ERK (39) and AKT (40) enhance cell survival by stimulating phosphorylation in downstream targets, thereby serving a protective role in the lung. Furthermore, the anti-apoptotic effect of HSP70 is closely associated with the ERK (41) and AKT (42) pathways. To gain further insight into the mechanism by which HSP70 protects against hypoxia/reoxygenation-induced apoptosis, the present study assessed the role of the MAPK/ERK and PI3K/AKT signaling pathways. The results revealed that decreased levels of HSP70 were accompanied with a decrease in p-ERK and p-AKT, indicating that HSP70 is required for ERK and AKT phosphorylation. In addition, the inhibition of ERK and AKT phosphorylation by their respective inhibitors also resulted in a decrease in HSP70 expression. Therefore, the present results indicate that HSP70 may function in an anti-apoptotic manner via the MAPK/ERK and PI3K/AKT signaling pathways.
In conclusion, HSP70 provided protection against hypoxia/reoxygenation. Silencing HSP70 was revealed to decrease cell viability and increase apoptosis in LIRI, which was accompanied by the inhibition of the ERK and AKT signaling pathways. The present study also highlighted the potential role of HSP70 in lung protection. Therefore, it is hypothesized that HSP70 may be a potential target for the treatment of LIRI. Although A549 cells have many features of normal type II alveolar epithelial cells, there are also differences between them (43) . Therefore, the in-vivo protective effects of HSP70 require further study. 
